Cases & Deals

Burrill & Company invest in xDX

Clients Burrill & Company LLC

Jones Day advised Burrill & Company LLC in connection with its purchase of $25 million of Series F Convertible Preferred Stock in a private placement by xDX Inc., a molecular diagnostics company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.